These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7833680)

  • 1. Pathogenesis of Graves' ophthalmopathy.
    Gorman CA
    Thyroid; 1994; 4(3):379-83. PubMed ID: 7833680
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of Graves' ophthalmopathy.
    Bahn RS; Heufelder AE
    N Engl J Med; 1993 Nov; 329(20):1468-75. PubMed ID: 8413459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):162-4. PubMed ID: 2144488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.
    Grubeck-Loebenstein B; Trieb K; Sztankay A; Holter W; Anderl H; Wick G
    J Clin Invest; 1994 Jun; 93(6):2738-43. PubMed ID: 8201012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue.
    McLachlan SM; Prummel MF; Rapoport B
    J Clin Endocrinol Metab; 1994 May; 78(5):1070-4. PubMed ID: 8175962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of peripheral B lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
    Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral autoimmune responses against human eye muscle membrane antigen in Graves' disease.
    Molnár I; Németi K; Bokk A; Stenszky V; Balázs C; Farid NR
    Acta Med Hung; 1990; 47(1-2):43-51. PubMed ID: 2280995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N; Inoue K; Mori R
    J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes.
    Okita N; How J; Topliss D; Lewis M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1002-7. PubMed ID: 7026590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
    Burch HB; Sellitti D; Barnes SG; Nagy EV; Bahn RS; Burman KD
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1384-91. PubMed ID: 8200941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.